Test Price
2,800 AED✅ Home Collection Available
TNNT3 Gene (Arthrogryposis, Distal, Type 2B) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) Accredited Processing – complete TNNT3 gene coverage.
- Premium Logistics: Paid Hospital‑Grade Home Collection (8 AM – 11 PM) using ISO‑Certified Cold‑Chain Transport; VIP Mobile Phlebotomy included.
- Clinical Guidance: Telephonic post‑test clinical interpretation by a DHA‑licensed genetic specialist, integrated with your physician’s care plan.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 – instant pre‑approval check.
Test Overview & Methodology
The TNNT3 gene test uses high‑coverage Next‑Generation Sequencing (NGS) to detect pathogenic variants responsible for distal arthrogryposis type 2B, enabling definitive diagnosis, familial risk assessment, and personalised management. This test can be ordered for affected individuals, at‑risk relatives, and carrier screening.
| Feature | Our Test (NGS – Complete TNNT3) | Closest Alternative (Sanger Single‑Gene) |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) | Conventional Sanger Sequencing |
| Coverage | All exons + splice sites (±20 bp) | Selected exons only (common mutations) |
| Turnaround Time | 3–4 Weeks (ISO‑Certified Lab) | 6–8 Weeks (non‑accredited often) |
| Accreditation | ISO 9001:2015 + DHA Licensed Facility | Variable / No UAE‑specific recognition |
| Clinical Support | Post‑test tele‑guidance & genetic counselling | Generally not included |
Physician Insight & Safety Protocols
“Every TNNT3 result must be interpreted in the context of a detailed phenotype and family history. A negative NGS finding does not rule out other distal arthrogryposis subtypes, and clinical correlation remains essential. I strongly advise patients to involve a medical geneticist or their referring physician when reviewing results to avoid misinterpretation and unwarranted anxiety.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Clinical Guidance
Pre-test genetic counselling is strongly recommended for all patients. Results should be integrated with a complete physical examination, family history, and any previous genetic testing. Do not base treatment decisions solely on this genetic report without consultation with a qualified medical geneticist.
Safety Exclusion Criteria & Emergency Red Flags
- Do not order during acute intercurrent illness that could delay or complicate sample collection.
- Patients with active bleeding disorders or severe anaemia must disclose before venipuncture.
- If the patient experiences sudden worsening of joint contractures, respiratory distress, or feeding difficulties, seek immediate emergency medical attention – do not wait for test results.
- Medication warning: Do not discontinue prescribed medications or therapies without consulting your physician. Genetic diagnosis does not replace ongoing multidisciplinary care.
Patient FAQ & Clinical Guidance
1. What exactly does the TNNT3 NGS test detect, and how reliable is it?
This NGS test detects single nucleotide variants, small insertions/deletions, and copy number changes across the entire TNNT3 gene, providing a definitive molecular diagnosis with >99.9% analytical sensitivity for the intended mutations.
2. What samples are accepted and how long does it take to get your results?
We accept whole blood, extracted DNA, or a single drop of blood on an FTA card; the turnaround time is 3 to 4 weeks from sample receipt at our ISO‑accredited facility.
3. Is this covered by insurance, and can your family be tested?
Many UAE insurers cover medically necessary genetic testing; our team verifies your coverage instantly via WhatsApp at +971 54 548 8731 and can arrange cascade screening for at‑risk relatives after confirming the familial variant.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143) in Dubai Healthcare City. All genetic data are processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information remains confidential and is not shared without your explicit consent.
Clinical & Logistical Metadata
| Test Name | TNNT3 Gene (Arthrogryposis, Distal, Type 2B) Genetic Test – NGS Full Gene Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Q74.3 |
| LOINC Code | 81316-3 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians